Lupin Limited (BOM:500257)
India · Delayed Price · Currency is INR 1,990.00
+2.50 (0.13%)
At close: Nov 6, 2026
Lupin Market Cap
Lupin has a market cap or net worth of 909.9 billion as of November 6, 2026. It is the 2,162nd most valuable company in the world and the 128th biggest in India. Its market cap has decreased by 0.30% in one year.
Market Cap
909.90B
Enterprise Value
896.28B
Revenue
307.46B
Global Rank
Country Rank
#128 India
PE Ratio
17.54
ChartMarket Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 909.90B, an increase of 91,059.46%. That is a compound annual growth rate of 28.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 909.90B | -5.69% |
| Dec 31, 2025 | 964.76B | -10.05% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.80T |
| Dr. Reddy's Laboratories | 1.14T |
| Abbott India | 559.71B |
| GlaxoSmithKline Pharmaceuticals | 427.72B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 198.23B |
| Caplin Point Laboratories | 181.01B |
| AstraZeneca Pharma India | 159.70B |